iBio Inc (IBIO)
2.18
-0.14
(-6.03%)
USD |
NYAM |
Nov 14, 16:00
2.18
0.00 (0.00%)
After-Hours: 20:00
iBio Free Cash Flow (Quarterly): -4.854M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -4.854M |
| March 31, 2024 | -3.654M |
| December 31, 2023 | -4.706M |
| September 30, 2023 | -5.34M |
| June 30, 2023 | -5.476M |
| March 31, 2023 | -3.671M |
| December 31, 2022 | -10.59M |
| September 30, 2022 | -16.44M |
| June 30, 2022 | -14.93M |
| March 31, 2022 | -8.021M |
| December 31, 2021 | -12.82M |
| September 30, 2021 | -13.34M |
| June 30, 2021 | -9.781M |
| March 31, 2021 | -8.366M |
| December 31, 2020 | -9.426M |
| September 30, 2020 | -7.653M |
| June 30, 2020 | -4.687M |
| March 31, 2020 | -3.882M |
| December 31, 2019 | -3.613M |
| September 30, 2019 | -2.317M |
| June 30, 2019 | -4.565M |
| March 31, 2019 | -4.274M |
| December 31, 2018 | -5.059M |
| September 30, 2018 | -1.067M |
| June 30, 2018 | -3.657M |
| Date | Value |
|---|---|
| March 31, 2018 | -3.985M |
| December 31, 2017 | -3.789M |
| September 30, 2017 | -3.128M |
| June 30, 2017 | -4.29M |
| March 31, 2017 | -3.864M |
| December 31, 2016 | -3.727M |
| September 30, 2016 | -2.875M |
| June 30, 2016 | -2.882M |
| March 31, 2016 | -2.439M |
| December 31, 2015 | -1.654M |
| September 30, 2015 | -1.165M |
| June 30, 2015 | -1.27M |
| March 31, 2015 | -1.377M |
| December 31, 2014 | -1.692M |
| September 30, 2014 | -0.601M |
| June 30, 2014 | -0.743M |
| March 31, 2014 | -1.345M |
| December 31, 2013 | -1.317M |
| September 30, 2013 | -0.97M |
| June 30, 2013 | -0.946M |
| March 31, 2013 | -1.293M |
| December 31, 2012 | -1.457M |
| September 30, 2012 | -1.348M |
| June 30, 2012 | -1.100M |
| March 31, 2012 | -3.020M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-16.44M
Minimum
Sep 2022
-3.613M
Maximum
Dec 2019
-7.960M
Average
-7.653M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.58M |
| Palatin Technologies Inc | -6.477M |
| Theriva Biologics Inc | -3.453M |
| Oragenics Inc | -1.544M |
| Nanoviricides Inc | -1.580M |